Kim Wolff King's College London, UKKim Wolff is Professor of Addiction Science, at King's College London and has worked in the Addiction field for the last 25 years. Her PhD thesis investigated the pharmacokinetics of methadone in heroin dependent drug addicts at the Research School of Medicine, University of Leeds. Professor Wolff's main research interest is concerned with biomarkers of substance misuse and she has acted as an expert advisor to the UK Government National Treatment Agency for Substance Misuse (NTA); the National Collaborating Centre for Mental Health (NCCMH) and the National Institute for Clinical Excellence (NICE) in this regard. Her work has led to advancement in the area of biomarkers for High Risk Drinking-Drivers demonstrating the clinical efficacy of carbohydrate deficient transferrin (CDT) in high-risk drink-drivers. The findings of this research resulted in a change of national policy for the Driver Vehicle Licensing Agency (DVLA), which has made CDT the sole biomarker for use by medical practitioners to aid decision making with regard to relicensing high risk drink drivers.
Professor Wolff is currently a panel member of the UK Secretary of State for Transport Medical Advisory Panel on Alcohol, Drugs & Substance Misuse & Driving. She chaired the expert Panel on drug-driving for the Department for Transport (2012) and led on the Panel's report, which made a significant contribution to the development of the new drug driving legislation that into force in England and Wales on march 2nd 2015. Professor Wolff has edited several books and published extensively in the peer reviewed literature. In 2016 Professor Wolff was made a Member of the Most Excellent Order of the British Empire (MBE) in the New Year's Honours list for services to road safety.